Effect of intravenous lidocaine on the 50% effective dose of ciprofol in inhibiting gastroscope insertion reaction

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300075224

Enrollment

Unknown

Registered

2023-08-30

Start date

2023-08-31

Completion date

Unknown

Last updated

2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless gastroscope

Interventions

Group C:Induction of anesthesia by intravenous injection of physiological saline, ketamine, and cyclophenol

Group L:Intravenous injection of lidocaine, ketamine, and cyclophenol for anesthesia induction

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Gender, age 18 - 65 years, BMI 18 - 28 kg/m2, ASA I or II

Exclusion criteria

Exclusion criteria: Patient requested withdrawal from the study; history of allergy to relevant drugs; Drug abuse history; severe organ dysfunction; Moderate to severe anemia or malnutrition; acute upper gastrointestinal bleeding; Cognitive dysfunction.

Design outcomes

Primary

Measure	Time frame
median effective dose;	—

Secondary

Measure	Time frame
Gastroscope insertion reaction;	—

Countries

China

Contacts

Public ContactHai Xu

No. 1518, Huancheng North Road, Jiaxing City Zhejiang Province

xhjxey@163.com+86 159 8837 5602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026